The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/500 - 1/1000. Detects a band of approximately 43 kDa (predicted molecular weight: 43 kDa).
Use a concentration of 1 - 5 µg/ml.
Four types of regulatory chains are found: I-alpha, I-beta, II-alpha, and II-beta. Their expression varies among tissues and is in some cases constitutive and in others inducible.
Defects in PRKAR1A are the cause of Carney complex type 1 (CNC1) [MIM:160980]. CNC is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas. Defects in PRKAR1A are the cause of intracardiac myxoma (INTMYX) [MIM:255960]. Inheritance is autosomal recessive. Defects in PRKAR1A are the cause of primary pigmented nodular adrenocortical disease type 1 (PPNAD1) [MIM:610489]. Primary pigmented nodular adrenocortical disease is a rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. PPNAD1 is most often diagnosed in patients with Carney complex, but it can also be observed in patients without other manifestations or familial history.
Belongs to the cAMP-dependent kinase regulatory chain family. Contains 2 cyclic nucleotide-binding domains.
The pseudophosphorylation site binds to the substrate-binding region of the catalytic chain, resulting in the inhibition of its activity.
cAMP dependent protein kinase regulatory subunit alpha 1 antibody
cAMP dependent protein kinase regulatory subunit RIalpha antibody
cAMP dependent protein kinase type I alpha regulatory chain antibody
cAMP dependent protein kinase type I alpha regulatory subunit antibody
cAMP-dependent protein kinase type I-alpha regulatory subunit antibody
Carney complex type 1 antibody
CNC 1 antibody
PKA RIA antibody
PKR 1 antibody
PPNAD 1 antibody
PRKAR 1 antibody
PRKAR1A/RARA FUSION GENE antibody
Protein kinase A type 1a regulatory subunit antibody
Protein kinase cAMP dependent regulatory type I alpha antibody
PTC2 CHIMERIC ONCOGENE, INCLUDED antibody
Tissue specific extinguisher 1 antibody
Tissue-specific extinguisher 1 antibody
TSE 1 antibody
Anti-Protein Kinase A regulatory subunit I alpha antibody 画像
Western blot - Anti-Protein Kinase A regulatory subunit I alpha antibody (ab65013)
All lanes : Anti-Protein Kinase A regulatory subunit I alpha antibody (ab65013) at 1/500 dilution
Lane 1 : HepG2 cell extract Lane 2 : HepG2 cell extract with immunizing peptide at 5 µg
Lysates/proteins at 10 µg per lane.
Predicted band size : 43 kDa Observed band size : 43 kDa
Immunocytochemistry/ Immunofluorescence - Anti-Protein Kinase A regulatory subunit I alpha antibody (ab65013)
ICC/IF image of ab65013 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab65013, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
Anti-Protein Kinase A regulatory subunit I alpha antibody (ab65013) 使用論文
This product has been referenced in:
Zhou L et al. Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac. Transl Psychiatry6:e881 (2016).
Read more (PubMed: 27598965) »